LONDON (dpa-AFX Broker) - The British investment bank Barclays has lowered its price target for Schott Pharma from 30 to 25 euros after quarterly figures and reduced business targets for the pharmaceutical supplier, but left the rating at "Equal Weight". He had lowered his estimates for organic sales growth in the 2024/25 financial year, which starts on October 1, from 18 to 10 percent, analyst Gaurav Jain wrote in a study published on Wednesday./la/men

Publication of the original study: 14.05.2024 / 21:04 / GMT First dissemination of the original study: 15.05.2024 / 03:00 / GMT

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------